Search - tctmd.com

Displaying 441 - 460 of 519

Sort: Relevancy | Date

News Daily News

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

August 14, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

Presentation

Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS

Presenter: 78830|Thomas Povsic

August 09, 2012

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Daily News

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Caitlin E. Cox

July 16, 2012

News Daily News

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Caitlin E. Cox

July 16, 2012

Presentation

Oral Anticoagulation Therapy in A-Fib Pts at High Bleeding Risk Undergoing Coronary Artery Stenting

Presenter: 204943|JM Ruiz-Nodar

July 13, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

Yael L. Maxwell

June 27, 2012

News Daily News

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

Jason Kahn

June 22, 2012

News Daily News

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Jason Kahn

June 22, 2012

News Daily News

Door Still Not Shut on CLOSURE I

Yael L. Maxwell

June 15, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Caitlin E. Cox

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

Advertisement

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Phase II Study Assessing the Efficacy, Safety of Variable Anticoagulation Reversal with REG1 in ACS

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

La Anticoagulación Protege a aquellos Pacientes con FA que se someten a PCI, a pesar del Riesgo Hemorrágico

Anticoagulation Protects A-Fib Patients Undergoing PCI, Despite Bleeding Risk

Oral Anticoagulation Therapy in A-Fib Pts at High Bleeding Risk Undergoing Coronary Artery Stenting

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Rates of Silent Stroke Similar for Radial, Femoral Cath in Aortic Disease Patients

RE-LY: El Dabigatran Acorta la Interrupción del Fármaco sin Aumentar los Episodios Hemorrágicos

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Door Still Not Shut on CLOSURE I

Rivaroxaban May be Cost-Effective for A-fib Patients

Watchman Works Just as Well Without Warfarin-Protected Transition

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content